|View printer-friendly version|
|Array CEO Robert E. Conway to Speak at the Thomas Weisel Partners' Healthcare Tailwinds 2003 Conference|
BOULDER, Colo., Aug. 21 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Thomas Weisel Partners' Healthcare Tailwinds 2003 Conference on September 3 in Boston. The public is welcome to listen to the presentation through an audio webcast on the Array BioPharma website. The presentation will also be hosted as an archived audio webcast for a period of 30 days.
About Array BioPharma:
Array BioPharma is a drug discovery company creating new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use our integrated set of drug discovery technologies, which we call the Array Discovery Platform, to invent drugs in collaboration with leading pharmaceutical and biotechnology companies and for our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com .
SOURCE Array BioPharma Inc.
/CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, firstname.lastname@example.org /
/Web site: http://www.arraybiopharma.com /